[Anti-anginal action of a combination of a beta-blocking agent, butydrine, with a nitroderivative with prolonged action, pentaerythrite. Clinical evaluation].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D006801:Humans; D011409:Propylene Glycols / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011409:Propylene Glycols; D013565:Sympatholytics
L'azione antianginosa di un'associazione beta-bloccante, la butidrina, con un nitroderivato ad azione protratta, il pentaeritrite. Valutazione clinica.